Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Influence of cohorting patients with Clostridium difficile infection on risk of symptomatic recurrence.

Islam J, Cheek E, Navani V, Rajkumar C, Cohen J, Llewelyn MJ.

J Hosp Infect. 2013 Sep;85(1):17-21. doi: 10.1016/j.jhin.2013.06.009. Epub 2013 Aug 1.

PMID:
23910403
2.

Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.

Harpe SE, Inocencio TJ, Pakyz AL, Oinonen MJ, Polk RE.

Pharmacotherapy. 2012 Aug;32(8):744-54. doi: 10.1002/j.1875-9114.2012.01160.x.

PMID:
23307522
3.

Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.

Rodriguez S, Hernandez MB, Tarchini G, Zaleski M, Vatanchi M, Cardona L, Castro-Pavia F, Schneider A.

Clin Gastroenterol Hepatol. 2014 Nov;12(11):1856-61. doi: 10.1016/j.cgh.2014.02.040. Epub 2014 Mar 27.

PMID:
24681079
4.

Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.

Ramanathan S, Johnson S, Burns SP, Kralovic SM, Goldstein B, Smith B, Gerding DN, Evans CT.

Am J Infect Control. 2014 Feb;42(2):168-73. doi: 10.1016/j.ajic.2013.08.009.

PMID:
24485372
5.

Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.

Freedberg DE, Salmasian H, Friedman C, Abrams JA.

Am J Gastroenterol. 2013 Nov;108(11):1794-801. doi: 10.1038/ajg.2013.333. Epub 2013 Sep 24.

6.

A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.

Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL.

J Hosp Infect. 2008 Oct;70(2):142-7. doi: 10.1016/j.jhin.2008.06.026. Epub 2008 Aug 23.

PMID:
18723249
7.

Recurrent Clostridium difficile infection is associated with increased mortality.

Olsen MA, Yan Y, Reske KA, Zilberberg MD, Dubberke ER.

Clin Microbiol Infect. 2015 Feb;21(2):164-70. doi: 10.1016/j.cmi.2014.08.017. Epub 2014 Oct 12.

8.

Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.

Li Y, Qian J, Queener E, Shen B.

Inflamm Bowel Dis. 2013 Feb;19(2):397-403. doi: 10.1097/MIB.0b013e318280fcb9.

PMID:
23328770
9.

Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.

Jardin CG, Palmer HR, Shah DN, Le F, Beyda ND, Jiang Z, Garey KW.

J Hosp Infect. 2013 Sep;85(1):28-32. doi: 10.1016/j.jhin.2013.04.017. Epub 2013 Jul 5.

PMID:
23834988
10.

Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.

Barletta JF, El-Ibiary SY, Davis LE, Nguyen B, Raney CR.

Mayo Clin Proc. 2013 Oct;88(10):1085-90. doi: 10.1016/j.mayocp.2013.07.004. Epub 2013 Sep 5.

PMID:
24012413
11.

Outcomes in community-acquired Clostridium difficile infection.

Khanna S, Pardi DS, Aronson SL, Kammer PP, Baddour LM.

Aliment Pharmacol Ther. 2012 Mar;35(5):613-8. doi: 10.1111/j.1365-2036.2011.04984.x. Epub 2012 Jan 10.

12.

Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.

Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A, Andreoli AL, Rodriguez-Otero P, Dhedin N, SociƩ G, Ribaud P, Peffault de Latour R.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1295-301. doi: 10.1016/j.bbmt.2012.02.010. Epub 2012 Feb 28.

13.

Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients.

Shah K, Pass LA, Cox M, Lanham M, Arnold FW.

J Trauma Acute Care Surg. 2012 Mar;72(3):691-5. doi: 10.1097/TA.0b013e31823c5637.

PMID:
22491554
14.

Hospital-acquired Clostridium difficile infection: determinants for severe disease.

Wenisch JM, Schmid D, Kuo HW, Simons E, Allerberger F, Michl V, Tesik P, Tucek G, Wenisch C.

Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1923-30. doi: 10.1007/s10096-011-1522-5. Epub 2011 Dec 31.

PMID:
22210266
15.

The appendix may protect against Clostridium difficile recurrence.

Im GY, Modayil RJ, Lin CT, Geier SJ, Katz DS, Feuerman M, Grendell JH.

Clin Gastroenterol Hepatol. 2011 Dec;9(12):1072-7. doi: 10.1016/j.cgh.2011.06.006. Epub 2011 Jun 13.

PMID:
21699818
16.

Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.

Huang H, Wu S, Chen R, Xu S, Fang H, Weintraub A, Nord CE.

Anaerobe. 2014 Dec;30:65-9. doi: 10.1016/j.anaerobe.2014.08.015. Epub 2014 Sep 8.

PMID:
25219941
17.

Risk factors and outcomes associated with severe clostridium difficile infection in children.

Kim J, Shaklee JF, Smathers S, Prasad P, Asti L, Zoltanski J, Dul M, Nerandzic M, Coffin SE, Toltzis P, Zaoutis T.

Pediatr Infect Dis J. 2012 Feb;31(2):134-8. doi: 10.1097/INF.0b013e3182352e2c.

PMID:
22031485
18.

Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group.

Price V, Portwine C, Zelcer S, Ethier MC, Gillmeister B, Silva M, Schindera C, Yanofsky R, Mitchell D, Johnston DL, Lewis V, Dix D, Cellot S, Michon B, Bowes L, Stobart K, Brossard J, Beyene J, Sung L.

Pediatr Infect Dis J. 2013 Jun;32(6):610-3. doi: 10.1097/INF.0b013e31828690a4.

PMID:
23838731
19.

Best strategies in recurrent or persistent Clostridium difficile infection.

Cocanour CS.

Surg Infect (Larchmt). 2011 Jun;12(3):235-9. doi: 10.1089/sur.2010.080. Epub 2011 Jul 18. Review.

PMID:
21767157
20.

Predictors of first recurrence of Clostridium difficile infection: implications for initial management.

Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, Finney J, O'Connor L, Vaughan A, Crook DW, Wilcox MH, Peto TE; Infections in Oxfordshire Research Database..

Clin Infect Dis. 2012 Aug;55 Suppl 2:S77-87. doi: 10.1093/cid/cis356.

Supplemental Content

Support Center